Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricINCYIncyteBNTXBiontech SEMRNAModerna
Snapshot
Price$127.48$103.55$149.19
Market cap$23.35B$24.67B$31.65B
Valuation
P/E17.8x——
Forward P/E12.7x——
Growth
Revenue growth21.5%-11.8%-30.0%
EPS growth2455.3%——
Profitability
Net margin26.7%-34.0%-143.6%
ROE29.2%-6.7%-36.7%
Balance sheet & cash
Debt / equity0.01x0.01x0.07x
Free cash flow yield2.2%13.6%-13.6%
Dividend yield———
Verdict
Investment ratingStrong· 86Weak· 31Weak· 17

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearINCYtoday $127BNTXtoday $104MRNAtoday $149
2027$2,443.13 – $3,583.26+2711% CAGR$79.22 – $116.18+12% CAGR$114.13 – $167.39+12% CAGR
2028$62,429.59 – $91,563.40+2580% CAGR$80.80 – $118.51+7% CAGR$116.41 – $170.74+7% CAGR
2029$1,595,269.65 – $2,339,728.81+2538% CAGR$82.42 – $120.88+5% CAGR$118.74 – $174.15+5% CAGR
2030$40,764,084.80 – $59,787,324.37+2517% CAGR$84.06 – $123.29+4% CAGR$121.12 – $177.64+4% CAGR
2031$1,041,648,735.26 – $1,527,751,478.38+2504% CAGR$85.75 – $125.76+4% CAGR$123.54 – $181.19+4% CAGR
5-yr CAGR2312.4% – 2504.5%-3.7% – 4.0%-3.7% – 4.0%